Free shipping on all orders over $ 500

Satraplatin

Cat. No. M28129
Satraplatin Structure
Synonym:

BMS182751; BMY45594; JM216

Size Price Availability Quantity
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Satraplatin is an alkylating agent, with potent antitumor effect.

Chemical Information
Molecular Weight 500.28
Formula C10H22Cl2N2O4Pt
CAS Number 129580-63-8
Form Solid
Solubility (25°C) DMF 10 mg/mL (ultrasonic and adjust pH to 1 with HCl, DMSO can inactivate Satraplatin's activity)
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Thilo Zander, et al. Anticancer Res. Satraplatin Demonstrates High Cytotoxic Activity Against Genetically Defined Lymphoid Malignancies

[2] Gury Doshi, et al. Expert Opin Drug Metab Toxicol. Clinical and pharmacokinetic evaluation of satraplatin

[3] Ashish Bhargava, et al. Expert Opin Investig Drugs. Satraplatin: leading the new generation of oral platinum agents

[4] Guru Sonpavde, et al. Future Oncol. Satraplatin for the therapy of castration-resistant prostate cancer

[5] Hak Choy. Expert Rev Anticancer Ther. Satraplatin: an orally available platinum analog for the treatment of cancer

Related DNA Alkylator/Crosslinker Products
LP-284

LP-284 is a potent DNA alkylating agent that kills solid tumours. LP-284 can be used in the studies of hematologic cancers with compromised DNA repair, such as mantle cell lymphoma (MCL).

4-Hydroperoxy cyclophosphamide

4-Hydroperoxy cyclophosphamide, the active metabolite form of the precursor Cyclophosphamide, cross-links DNA and induces T-cell apoptosis independent of caspase receptor activation, as well as activating the mitochondrial death pathway through the generation of reactive oxygen species (ROS). It can be used in studies related to rheumatoid arthritis and autoimmune diseases.

Diaziquone

Diaziquone is a water-soluble synthetic aziridinyl benzoquinone that selectively alkylates and cross-links DNA, inhibits DNA replication, induces apoptosis, and inhibits the proliferation of tumor cells, with potential antitumor activity.

Semustine

Semustine is a methylated derivative of Carmustine and also a DNA alkylating agent, which can form covalent bonds with nucleophilic centers in DNA, causing depurination, base pair miscoding, strand breaks, and DNA-DNA cross-linking, and has antitumor activity.

Methyl methanesulfonate

Methyl methanesulfonate is a SN2-type alkylating agent that primarily methylates the nitrogen atom in purines and has apoptosis-inducing effects.

  Catalog
Abmole Inhibitor Catalog




Keywords: Satraplatin, BMS182751; BMY45594; JM216 supplier, DNA Alkylator/Crosslinker, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.